Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJardine Math.sr Regulatory News (JAR)

Share Price Information for Jardine Math.sr (JAR)

Share Price is delayed by 15 minutes
Get Live Data
62.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 0.00 (0.00%)
Market Cap: $18.42b
JAR Live PriceLast checked at - London Stock Exchange

Intraday Jardine Math.sr Share Chart

Interim Management Statement

9 Apr 2020 10:21

RNS Number : 3649J
Mandarin Oriental International Ltd
09 April 2020
 

The following announcement has been issued to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

9th April 2020 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2020.

 

The Group's performance was severely impacted by the COVID-19 pandemic, resulting in an unaudited underlying loss of some US$40 million in the first quarter. A majority of the Group's hotels are now effectively closed and, while most hotels in Asia remain open, they are experiencing single digit percentage occupancy levels.

 

The Group has taken a number of actions to manage costs and preserve cash. These include the suspension of non-essential expenses and capital expenditure, significantly reducing payroll costs through unpaid leave, furloughing, substantial voluntary salary reductions at all levels and participation in government support measures wherever possible. The payroll measures have been taken proportionate to the seniority and means of colleagues. The Directors would like to express their deep gratitude for the continuing dedication and resolve of colleagues during these difficult times.

 

It is too early to forecast the duration of the impact of COVID-19 on the business but, as a result of the substantial reduction in revenue and management fees from the Group's hotels, the underlying loss in the second quarter is expected to be larger than in the first quarter.

 

In light of the exceptional circumstances, the Directors have withdrawn their recommendation of a final dividend in respect of the 2019 financial year and the relevant resolution seeking approval for the payment of the dividend will no longer be put to shareholders at the Company's AGM on 6th May 2020.

 

The Group's balance sheet and liquidity position both remain strong and will enable it to sustain the current low levels of business activity for an extended period of time. At 31st March 2020, net debt was US$363 million compared to net debt of US$300 million at the end of 2019. Gearing was 6% of adjusted shareholders' funds. During the quarter, the Group invested US$19 million in the restoration of Mandarin Oriental Ritz, Madrid.

 

At 31st March 2020, in addition to US$229 million of cash reserves, the Group also had US$207 million in available debt facilities that are committed for four years. The Group's facilities are not subject to any cash flow covenants.

 

While the Group's operations are currently being dramatically impacted by events associated with the COVID-19 pandemic, Mandarin Oriental remains a powerful brand that is well positioned to benefit over the long-term, when demand for luxury travel returns.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

Brunswick Group Limited

David Ashton (852) 3512 5063

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKLBBBZLFBBV
Date   Source Headline
8th Apr 20221:02 pmRNSCorrection: TRANS Date-Director/PDMR Shareholding
7th Apr 202210:28 amRNSAnnual Financial Report
4th Apr 20221:12 pmRNSDirector/PDMR Shareholding
31st Mar 20221:18 pmRNSTotal Voting Rights
30th Mar 202210:58 amRNSCirc re. Scrip Dividend Scheme
25th Mar 202211:50 amRNSBlock listing Interim Review
25th Mar 202211:24 amRNSDirector/PDMR Shareholding
23rd Mar 202212:27 pmRNSDirector/PDMR Shareholding
15th Mar 20229:27 amRNSDirector/PDMR Shareholding
4th Mar 202210:30 amRNSTransaction in Own Shares
3rd Mar 202211:22 amRNSTransaction in Own Shares
3rd Mar 202210:27 amRNS2021 Preliminary Announcement of Results
3rd Mar 20229:33 amRNS2021 Preliminary Announcement of Results
3rd Mar 20229:32 amRNSDirectorate Change
3rd Mar 20229:30 amRNS2021 Preliminary Announcement of Results
3rd Mar 20229:29 amRNS2021 Preliminary Announcement of Results
2nd Mar 20221:12 pmRNSTransaction in Own Shares
2nd Mar 202210:43 amRNSPT Hero Supermarket Tbk Full Year 2021 Results
1st Mar 202211:28 amRNSTransaction in Own Shares
28th Feb 202212:27 pmRNSJC&C - 2021 FY Results & Dividend
28th Feb 202211:13 amRNSTotal Voting Rights
28th Feb 202211:06 amRNSTransaction in Own Shares
28th Feb 202210:46 amRNS2021 Financial Statements & Dividend Announcement
25th Feb 20221:04 pmRNSTransaction in Own Shares
25th Feb 20229:50 amRNSPT Astra International Tbk (Astra) - FY Results
24th Feb 202210:56 amRNSTransaction in Own Shares
23rd Feb 202210:24 amRNSTransaction in Own Shares
22nd Feb 202210:24 amRNSTransaction in Own Shares
21st Feb 202210:40 amRNSTransaction in Own Shares
18th Feb 202211:38 amRNSTransaction in Own Shares
16th Feb 202211:16 amRNSTransaction in Own Shares
15th Feb 202210:09 amRNSTransaction in Own Shares
14th Feb 202210:49 amRNSTransaction in Own Shares
11th Feb 202210:09 amRNSTransaction in Own Shares
10th Feb 202211:42 amRNSTransaction in Own Shares
9th Feb 202210:14 amRNSTransaction in Own Shares
7th Feb 202210:32 amRNSTransaction in Own Shares
4th Feb 202210:18 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSTransaction in Own Shares
4th Feb 20227:00 amRNSDirector/PDMR Shareholding
31st Jan 20228:19 amRNSTotal Voting Rights
31st Jan 20227:53 amRNSTransaction in Own Shares
28th Jan 202211:19 amRNSTransaction in Own Shares
27th Jan 202212:51 pmRNSDirector/PDMR Shareholding
27th Jan 202211:28 amRNSTransaction in Own Shares
26th Jan 202210:29 amRNSTransaction in Own Shares
25th Jan 202210:38 amRNSTransaction in Own Shares
24th Jan 202210:42 amRNSTransaction in Own Shares
21st Jan 202212:02 pmRNSShare repurchase etc
20th Jan 202211:27 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.